Related Experiment Videos
[The approaches of chronic graft-versus-host disease]
1Department of Hematology, The General Hospital of PLA, Beijing 100853, China.
Insights
Chronic graft-versus-host disease (cGVHD) is a major complication after stem cell transplants, causing significant morbidity and mortality. Recent research advances are improving cGVHD diagnosis, prophylaxis, and treatment strategies.
Area of Science:
- Immunology
- Hematology
- Oncology
Context:
- Chronic graft-versus-host disease (cGVHD) is a significant long-term complication following allogeneic hematopoietic stem cell transplantation (HSCT).
- It represents the primary cause of morbidity and non-relapse mortality in HSCT survivors.
- Understanding the immune mechanisms underlying cGVHD is crucial for managing affected patients.
Purpose:
- To review current research progress in chronic graft-versus-host disease.
- To highlight advancements in the diagnosis, prophylaxis, and treatment of cGVHD.
- To provide an overview of the evolving landscape of cGVHD management.
Summary:
- This review synthesizes recent findings on the immune basis of cGVHD.
- It covers updated diagnostic criteria and prophylactic measures.
- Current therapeutic strategies and emerging treatments are discussed.
Impact:
- Improved understanding of cGVHD pathogenesis.
- Potential for earlier diagnosis and more effective prevention strategies.
- Advancements in treatment options may reduce cGVHD-related morbidity and mortality, improving long-term outcomes for HSCT survivors.
Abstract:
Chronic graft-versus-host disease (cGVHD) continues to be a major complication in long-term survivors after allogeneic hematopoietic stem cell transplantation and is the principal cause of morbidity and non-relapse mortality. With the new approaches in the immune mechanisms of cGVHD, the diagnosis, prophylaxis and treatment of cGVHD are involved. This review summarises the current progress of research on cGVHD.